Allergy Asthma Immunol Res.  2018 Jan;10(1):1-3. 10.4168/aair.2018.10.1.1.

Efficacy and Safety of Subcutaneous Allergen Immunotherapy for Allergic Rhinitis

Affiliations
  • 1Department of Pediatrics, Severance Hospital, Institute of Allergy, Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea. mhsohn@yuhs.ac

Abstract

No abstract available.


MeSH Terms

Desensitization, Immunologic*
Rhinitis, Allergic*

Cited by  5 articles

Microarray-Based Multivariate Analysis of the Effectiveness of Sublingual Immunotherapy for Cedar Pollinosis
Minoru Gotoh, Osamu Kaminuma, Takachika Hiroi, Kimihiro Okubo
Allergy Asthma Immunol Res. 2018;10(5):562-569.    doi: 10.4168/aair.2018.10.5.562.

Decreased CRTH2 Expression and Response to Allergen Re-stimulation on Innate Lymphoid Cells in Patients With Allergen-Specific Immunotherapy
Wat Mitthamsiri, Panitan Pradubpongsa, Atik Sangasapaviliya, Tadech Boonpiyathad
Allergy Asthma Immunol Res. 2018;10(6):662-674.    doi: 10.4168/aair.2018.10.6.662.

Comparison of Long-term Efficacy of Subcutaneous Immunotherapy in Pediatric and Adult Patients With Allergic Rhinitis
Yanran Huang, Chengshuo Wang, Feifei Cao, Yan Zhao, Hongfei Lou, Luo Zhang
Allergy Asthma Immunol Res. 2019;11(1):68-78.    doi: 10.4168/aair.2019.11.1.68.

Safety of Ultra-rush Schedule of Subcutaneous Allergen Immunotherapy With House Dust Mite Extract Conducted in an Outpatient Clinic in Patients With Atopic Dermatitis and Allergic Rhinitis
So-Hee Lee, Myoung-Eun Kim, Yoo Seob Shin, Young-Min Ye, Hae-Sim Park, Dong-Ho Nahm
Allergy Asthma Immunol Res. 2019;11(6):846-855.    doi: 10.4168/aair.2019.11.6.846.

Efficacy of Allergen Immunotherapy for Allergic Asthma in Real World Practice
Hyo-In Rhyou, Young-Hee Nam
Allergy Asthma Immunol Res. 2020;12(1):99-109.    doi: 10.4168/aair.2020.12.1.99.


Reference

1. Solé D, Rosário Filho NA, Sarinho ES, Camelo-Nunes IC, Barreto BA, Medeiros ML, et al. Prevalence of asthma and allergic diseases in adolescents: nine-year follow-up study (2003–2012). J Pediatr (Rio J). 2015; 91:30–35.
Article
2. Kim DH, Han K, Kim SW. Relationship between allergic rhinitis and mental health in the general Korean adult population. Allergy Asthma Immunol Res. 2016; 8:49–54.
Article
3. Ozdoganoglu T, Songu M. The burden of allergic rhinitis and asthma. Ther Adv Respir Dis. 2012; 6:11–23.
Article
4. Ciprandi G, Caimmi D, Miraglia Del Giudice M, La Rosa M, Salpietro C, Marseglia GL. Recent developments in United airways disease. Allergy Asthma Immunol Res. 2012; 4:171–177.
Article
5. Roberts G, Pfaar O, Akdis CA, Ansotegui IJ, Durham SR, Gerth van Wijk R, et al. EAACI guidelines on allergen immunotherapy: allergic rhinoconjunctivitis. Allergy. 2017; Forthcoming.
6. Terreehorst I, Hak E, Oosting AJ, Tempels-Pavlica Z, de Monchy JG, Bruijnzeel-Koomen CA, et al. Evaluation of impermeable covers for bedding in patients with allergic rhinitis. N Engl J Med. 2003; 349:237–246.
Article
7. Greiner AN, Hellings PW, Rotiroti G, Scadding GK. Allergic rhinitis. Lancet. 2011; 378:2112–2122.
Article
8. Noon L. Prophylactic inoculation against hay fever. Lancet. 1911; 177:1572–1573.
Article
9. Freeman J. Further observations on the treatment of hay fever by hypodermic inoculations of pollen vaccine. Lancet. 1911; 178:814–817.
Article
10. Alvarez-Cuesta E, Bousquet J, Canonica GW, Durham SR, Malling HJ, Valovirta E, et al. Standards for practical allergen-specific immunotherapy. Allergy. 2006; 61:Suppl 82. 1–20.
Article
11. Petalas K, Durham SR. Allergen immunotherapy for allergic rhinitis. Rhinology. 2013; 51:99–110.
Article
12. Seidman MD, Gurgel RK, Lin SY, Schwartz SR, Baroody FM, Bonner JR, et al. Clinical practice guideline: allergic rhinitis. Otolaryngol Head Neck Surg. 2015; 152:S1–S43.
13. Mortuaire G, Michel J, Papon JF, Malard O, Ebbo D, Crampette L, et al. Specific immunotherapy in allergic rhinitis. Eur Ann Otorhinolaryngol Head Neck Dis. 2017; 134:253–258.
Article
14. Erekosima N, Suarez-Cuervo C, Ramanathan M, Kim JM, Chelladurai Y, Segal JB, et al. Effectiveness of subcutaneous immunotherapy for allergic rhinoconjunctivitis and asthma: a systematic review. Laryngoscope. 2014; 124:616–627.
Article
15. Dretzke J, Meadows A, Novielli N, Huissoon A, Fry-Smith A, Meads C. Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison. J Allergy Clin Immunol. 2013; 131:1361–1366.
16. Dhami S, Nurmatov U, Arasi S, Khan T, Asaria M, Zaman H, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic review and meta-analysis. Allergy. 2017; 72:1597–1631.
Article
17. Lee JH, Kim SC, Choi H, Jung CG, Ban GY, Shin YS, et al. A retrospective study of clinical response predictors in subcutaneous allergen immunotherapy with house dust mites for allergic rhinitis. Allergy Asthma Immunol Res. 2018; 10:18–24.
Article
18. Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy. 2005; 60:4–12.
Article
19. Karakoc-Aydiner E, Eifan AO, Baris S, Gunay E, Akturk E, Akkoc T, et al. Long-term effect of sublingual and subcutaneous immunotherapy in dust mite–allergic children with asthma/rhinitis: a 3-year prospective randomized controlled trial. J Investig Allergol Clin Immunol. 2015; 25:334–342.
20. Eng PA, Borer-Reinhold M, Heijnen IA, Gnehm HP. Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood. Allergy. 2006; 61:198–201.
Article
21. Cox L, Larenas-Linnemann D, Lockey RF, Passalacqua G. Speaking the same language: the World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System. J Allergy Clin Immunol. 2010; 125:569–574. 574.e1–574.e7.
Article
22. Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev. 2007; CD001936.
Article
23. Moreno C, Cuesta-Herranz J, Fernández-Távora L, Alvarez-Cuesta E. Immunotherapy Committee, Sociedad Española de Alergología e Inmunología Clínica. Immunotherapy safety: a prospective multicentric monitoring study of biologically standardized therapeutic vaccines for allergic diseases. Clin Exp Allergy. 2004; 34:527–531.
Article
Full Text Links
  • AAIR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr